Access to Essential Medicines

Background:

Access to medicines that people need should be universally equitable and sustainable. The medicines should be safe, effective and of good quality. They should be prescribed by relevant authority and used rationally.

The majority of low and middle-income countries now use essential medicines lists in selecting their medicines. This may be further developed with the introduction of generic competition, which helps to maintain low prices. Schemes such as bulk purchasing, careful price comparison, compulsory licensing and differential pricing schemes, may all help countries obtain better purchasing prices for medicines, and also ensure sustainability of long-term pharmaco-healthcare provision.

Activities for Asia-Pacific (2007-2010) consist of 2 parts:

1.1 Medicine prices should never be an impediment to access -

  • Monitor the impact of national and international policy on medicine prices and press for access to be the driving principle of the implementation of these policies.
  • Research and lobby for fair financing for medicines.

Ongoing Projects:

Medicines Price Control
Healthcare Financing

1.2 Research and Development (R&D) re-oriented and rewarded according to public needs -

  • Monitor changes in legislation on intellectual property and their effects.
  • Assist goverments to enact public health-sensitive patent legislation in national laws by including provisions for compulsory licensing and parallel importing.

Ongoing Projects:

Free Trade Agreements & Intellectual Property Rights

Related News:

‘Impact of Financial Crisis on Health: A Truly Global Solution is Needed’ in HAI News #149

Main News Main News

HAI Latin America & Caribbean on Trade Agreements between Andean Countries & EU, in HAI News #149

EU Trade Agreement EU Trade Agreement

HAI Europe Press Release on the Impact of EU’s IP Agenda for Andean Countries, HAI News #149

EU's IP Agenda

HAI Africa: ‘Spot Survey Reveals Medicine Stock-Outs Still Plague Kenya’, HAI News #149

Snap Survey Snap Survey

‘R & D Costs: A Boon or Bane?’ in HAI News #148

HAI Europe reports on the impact of ‘CAN-EU Agreements on IP and Trade’ in HAI News #148

HAI Africa reports on their ‘Stock-Outs Campaign’ in HAI News #148

HAI Asia-Pacifc reports on a new ‘Consumers’ Coalition formed in the Philippines’ in HAI News #148